ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
ETHOS II
Enhancing Treatment of Hepatitis C in Opioid Substitution Settings II (ETHOS II): A Partnership Project to Enhance Hepatitis C Care in Drug and Alcohol Clinics
1 other identifier
interventional
6,000
1 country
32
Brief Summary
The overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and to develop a translational framework for subsequent establishment of HCV screening and treatment programs in drug treatment clinics and NSPs across NSW and nationally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2018
Longer than P75 for not_applicable
32 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2018
CompletedFirst Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
September 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
May 14, 2026
May 1, 2026
8.6 years
September 20, 2018
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants commencing anti-HCV treatment
Evaluation of number of participants commencing anti-HCV treatment
Every year post enrolment for up to 3 years
Study Arms (1)
Campaign Days
EXPERIMENTALAll participants have the intervention of the campaign days which include hepatitis C screening, fibroscans and clinical assessments.
Interventions
Participants who consent will complete study procedures (Hep C test, fibroscan, questionnaire, clinical assessment) and followed up through medical record review.
Eligibility Criteria
You may qualify if:
- Participant has voluntarily signed the informed consent form;
- years of age or older;
- History of injecting drug use\*;
- Recent injecting drug use (previous six months) or currently receiving OST\*.
- These criteria will not apply for recruitment from residential rehabilitation centres
You may not qualify if:
- Nil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (32)
Canberra Alliance for Harm Minimisation & Advocacy (CAHMA)
Canberra, Australian Capital Territory, 2617, Australia
Blacktown Methadone Management Clinic
Blacktown, New South Wales, 2148, Australia
NSLHD Brookvale Community Health Centre
Brookvale, New South Wales, 2100, Australia
Campbelltown Drug Health Services
Campbelltown, New South Wales, 2560, Australia
HNELHD Drug and Alcohol Clinical Services Cessnock
Cessnock, New South Wales, 2325, Australia
MNCLHD Coffs Harbour Alcohol and Other Drug Services
Coffs Harbour, New South Wales, 2450, Australia
Rankin Court Treatment Centre
Darlinghurst, New South Wales, 2010, Australia
NNSWLHD Grafton Alcohol and Other Drug Services
Grafton, New South Wales, 2460, Australia
NBMLHD Drug & Alcohol Services Katoomba
Katoomba, New South Wales, 2780, Australia
MNCLHD Kempsey Alcohol and Other Drug Services
Kempsey, New South Wales, 2440, Australia
NNSWLHD Lismore (Riverlands) Alcohol and Other Drug Services
Lismore, New South Wales, 2480, Australia
NBMLHD Drug & Alcohol Services Lithgow
Lithgow, New South Wales, 2790, Australia
Liverpool Opioid Treatment Program
Liverpool, New South Wales, 2170, Australia
WSLHD Mount Druitt Drug Health OST Clinic
Mount Druitt, New South Wales, 2770, Australia
HNELHD Drug and Alcohol Clinical Services Newcastle
Newcastle, New South Wales, 2300, Australia
Lawrence Avenue Methadone Program (LAMP)
Nowra, New South Wales, 2541, Australia
WSLHD Fleet Street Drug Health OST Clinic
Parramatta, New South Wales, 2150, Australia
MNCLHD Port Macquarie Alcohol and Other Drug Services
Port Macquarie, New South Wales, 2444, Australia
NSLHD Herbert Street Clinic
Saint Leonards, New South Wales, 2065, Australia
HNELHD Drug and Alcohol Clinical Services Tamworth
Tamworth, New South Wales, 2340, Australia
HNELHD Drug and Alcohol Clinical Services Taree
Taree, New South Wales, 2430, Australia
NNSWLHD Tweed Heads Alcohol and Other Drug Services
Tweed Heads, New South Wales, 2485, Australia
The Orana Centre
Wollongong, New South Wales, 2500, Australia
Biala City Community Health Centre
Brisbane, Queensland, 4034, Australia
Youthlink
Cairns, Queensland, 4870, Australia
Queensland Injectors Health Network (QuIHN)
Kirwan, Queensland, 4817, Australia
Townsville Sexual Health Services, North Ward Health Campus
Townsville, Queensland, 4810, Australia
Northern Drug and Alcohol Services South Australia (DASSA)
Elizabeth, South Australia, 5112, Australia
Central Drug and Alcohol Services South Australia (DASSA)
Stepney, South Australia, 5069, Australia
Next Step Fremantle
Fremantle, Western Australia, 6160, Australia
Next Step Joondalup
Joondalup, Western Australia, 6027, Australia
Next Step East Perth
Perth, Western Australia, 6004, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jason Grebely
The University of New South Wales
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2018
First Posted
September 26, 2018
Study Start
May 28, 2018
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
May 14, 2026
Record last verified: 2026-05